Monitoring of monoclonal antibodies for COVID-19: weekly report published

Monitoring of antivirals for COVID-19: new report published

ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines

COVID-19: extension of the target recipients of the second booster dose

Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines

Monitoring of antivirals for COVID-19: new report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published

EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU

EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17

Monitoring of antivirals for COVID-19: new report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published

Start of rolling review for adapted Spikevax COVID-19 vaccine

Start of rolling review for adapted Comirnaty COVID-19 vaccine

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022

Monitoring of antivirals for COVID-19: eleventh report published

Monitoring of monoclonal antibodies for COVID-19: weekly report published

CTS expands Evusheld prescription criteria for pre-exposure prophylaxis in subjects at high risk of severe Covid-19 disease

Modifiche Registro EVUSHELD profilassi COVID-19

Modifica Registro Anticorpi monoclonali COVID-19 (mAbs)

Modifica Registri - Antivirali orali COVID-19, Veklury trattamento precoce ed Anticorpi monoclonali COVID-19